publicationMetadata:
  pmid: "40529476"
  title: "Using Durometers to Quantify Stiffness as an Outcome Measure for Cutaneous Neurofibroma in Neurofibromatosis Type 1."
  queryType: "bench,clinical"  # From PubMed query (hint only)
  publicationType: "Clinical Study"
  publicationTypeConfidence: 0.95  # Confidence in the classification
  hasMethodsSection: Yes
  likelyContainsTools: Yes
  expectedToolTypes: |
    Based on publication type (Clinical Study):
    - Clinical assessment tools → Expected (physical measurement devices for clinical outcomes)
    - Computational tools → Expected (statistical analysis software mentioned: R 4.4.2)
    
    This clinical study evaluates two physical measurement instruments (durometers) for quantifying 
    cutaneous neurofibroma stiffness as a clinical outcome measure. The study involves patient 
    measurements using specialized devices, making clinical assessment tools highly expected.
    Statistical analysis using R software also indicates computational tools are present.
  overallAssessment: |
    This clinical study evaluates two durometer instruments for measuring neurofibroma stiffness 
    in NF1 patients, making it highly likely to contain clinical assessment tools. The study 
    includes detailed methods for instrument validation and statistical analysis using R software, 
    indicating both clinical measurement tools and computational analysis tools should be present.

toolValidations: []  # No tools were mined, so this section is empty

potentiallyMissedTools:
  - toolName: "Rex Gauge durometer"
    toolType: "clinical_assessment_tool"
    foundIn: "methods"
    contextSnippet: "One was the Rex Gauge durometer (REX) produced by Rex Gauge LLC...The REX is primarily used in manufacturing and is the international standard for determining the hardness of nonmetallic materials...The Rex Gauge durometer was the first instrument used to measure skin 'hardness'"
    whyMissed: "Physical measurement device used as clinical outcome measure - should be classified as clinical assessment tool for quantifying neurofibroma stiffness"
    confidence: 0.95
    shouldBeAdded: Yes

  - toolName: "Delfin SkinFibroMeter"
    toolType: "clinical_assessment_tool"
    foundIn: "methods"
    contextSnippet: "the other was the SkinFibroMeter (DEFLIN) made by Delfin Technologies...The DEFLIN is designed and marketed as an instrument to specifically measure tissue induration, assessing 'tissue stiffness in quantitative units.'"
    whyMissed: "Specialized medical device for measuring tissue stiffness - clear clinical assessment tool for quantifying patient outcomes"
    confidence: 0.95
    shouldBeAdded: Yes

  - toolName: "R"
    toolType: "computational_tool"
    foundIn: "methods"
    contextSnippet: "Statistical analyses were performed using R 4.4.2 software (R Foundation for Statistical Computing, Vienna, Austria)."
    whyMissed: "Statistical analysis software with specific version number - clear computational tool usage"
    confidence: 0.90
    shouldBeAdded: Yes

  - toolName: "Shore Hardness Scale"
    toolType: "clinical_assessment_tool"
    foundIn: "methods"
    contextSnippet: "The REX uses the Shore Hardness Scale (measured in scale units), which ranges from 0 to 100, with 0 being the softest."
    whyMissed: "Standardized measurement scale used for clinical assessment - could be considered a clinical assessment tool"
    confidence: 0.70
    shouldBeAdded: Maybe

suggestedPatterns:
  - patternType: "term"
    pattern: "durometer|SkinFibroMeter|Rex Gauge"
    toolType: "clinical_assessment_tool"
    examples: ["Rex Gauge durometer", "Delfin SkinFibroMeter"]
    reasoning: "Physical measurement devices used in clinical studies for patient assessment should be captured as clinical assessment tools"

  - patternType: "context_phrase"
    pattern: "Statistical analyses were performed using|analyzed using|software"
    toolType: "computational_tool"
    examples: ["Statistical analyses were performed using R 4.4.2 software"]
    reasoning: "Clear indication of computational tool usage in analysis context"

  - patternType: "naming_convention"
    pattern: "\\b[A-Z]+ [0-9]+\\.[0-9]+\\.[0-9]+\\b"
    toolType: "computational_tool"
    examples: ["R 4.4.2"]
    reasoning: "Software version patterns (name + version number) reliably indicate computational tools"

  - patternType: "vendor_indicator"
    pattern: "produced by|made by|\\(.*LLC\\)|\\(.*Technologies\\)"
    toolType: "clinical_assessment_tool"
    examples: ["produced by Rex Gauge LLC", "made by Delfin Technologies"]
    reasoning: "Vendor/manufacturer information often accompanies clinical measurement devices and instruments"

observations:
  - resourceName: "Rex Gauge durometer"
    resourceType: "Clinical Assessment Tool"
    observationType: "Usage Instructions"
    observationTypeOntologyId: ""  # No MP ID for usage instructions
    details: |
      The Rex Gauge durometer showed excellent within-visit agreement (intraclass correlation 
      coefficient = 0.937, 95% confidence interval = 0.913-0.953) and moderate within-tumor 
      agreement (intraclass correlation coefficient = 0.740, 95% confidence interval = 0.631-0.816) 
      when measuring cutaneous neurofibroma stiffness. The instrument was found to be easy to use 
      and reliable for consistent quantification of cNF stiffness.
    foundIn: "both"
    contextSnippet: "the REX had moderate within-tumor agreement (intraclass correlation coefficient = 0.740, 95% confidence interval = 0.631-0.816) and excellent within-visit agreement (intraclass correlation coefficient = 0.937, 95% confidence interval = 0.913-0.953)"
    confidence: 0.95
    doi: "10.1016/j.xjidi.2025.100380"

  - resourceName: "Delfin SkinFibroMeter"
    resourceType: "Clinical Assessment Tool"
    observationType: "Usage Instructions"
    observationTypeOntologyId: ""  # No MP ID for usage instructions
    details: |
      The Delfin SkinFibroMeter demonstrated moderate within-tumor agreement (intraclass correlation 
      coefficient = 0.607, 95% confidence interval = 0.512-0.691) and moderate within-visit agreement 
      (intraclass correlation coefficient = 0.732, 95% confidence interval = 0.665-0.786) for 
      measuring cutaneous neurofibroma stiffness. The instrument was found to be easy to use and 
      reliable, providing consistent quantification of cNF stiffness.
    foundIn: "both"
    contextSnippet: "The DELFIN had moderate within-tumor agreement (intraclass correlation coefficient = 0.607, 95% confidence interval = 0.512-0.691) and moderate within-visit agreement (intraclass correlation coefficient = 0.732, 95% confidence interval = 0.665-0.786)"
    confidence: 0.95
    doi: "10.1016/j.xjidi.2025.100380"

summary:
  totalToolsMined: 0
  toolsAccepted: 0
  toolsRejected: 0
  toolsUncertain: 0
  potentiallyMissedCount: 4  # Number of tools that might have been missed
  newPatternsCount: 4  # Number of new patterns suggested
  observationsExtracted: 2  # Number of scientific observations found
  observationsByType:  # Breakdown by observation type
    Usage Instructions: 2
  majorIssuesFound: |
    Major issues found during review:
    - No tools were mined from this publication despite clear presence of clinical assessment tools
    - Two specialized medical devices (Rex Gauge durometer, Delfin SkinFibroMeter) used for patient measurements were completely missed
    - Statistical analysis software (R 4.4.2) was not detected despite explicit mention with version number
    - Mining patterns appear inadequate for detecting clinical measurement devices and their associated scales
  recommendations: |
    Overall recommendations for this publication:
    - All 3-4 potentially missed tools should be added to the database (Rex Gauge durometer, Delfin SkinFibroMeter, R software, possibly Shore Hardness Scale)
    - This represents a significant mining failure - clinical assessment tools were completely missed despite clear usage context
    - Suggested patterns should be implemented to catch similar clinical measurement devices in future mining
    - The publication provides valuable validation data for both durometer instruments that should be captured as observations
    - Mining algorithms need improvement for detecting physical measurement devices used in clinical studies
    - Consider expanding clinical assessment tool patterns to include medical/scientific instruments with manufacturer information
